Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive TherapiesKim Papp, John Wade, Donald C. Vinh et al.|Journal of Cutaneous Medicine and Surgery|2018Cited by 124
Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and mononuclear cell subset profiles.Boulos Haraoui, Sharon M. Wahl, R L Wilder et al.|The Journal of Immunology|1984Cited by 50
Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive SummaryKim Papp, John Wade, Boulos Haraoui et al.|The Journal of Rheumatology|2019Cited by 27
Optimizing Use of Tumor Necrosis Factor Inhibitors in the Management of Immune-Mediated Inflammatory DiseasesBrian Bressler, Alessandro Sette, Boulos Haraoui et al.|Journal of Rheumatology Supplement|2010Cited by 17
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies—Executive SummaryKim Papp, John Wade, Boulos Haraoui et al.|Journal of the Canadian Association of Gastroenterology|2018Cited by 7